News
What you need to know about the H1N1 (Swine Flu) virus
An advisory from the Alpha-1 Foundation
People who have Alpha-1 Antitrypsin Deficiency and their caregivers should stay informed about the presence of H1N1 (Swine Flu) virus in their communities.
Flu is primarily a respiratory infection and respiratory infections can be more severe in people who have the types of medical conditions that those with Alpha-1 may have.
The Centers for Disease Control and Prevention (CDC) is currently compiling recommendations regarding populations at high risk for complications from the H1N1 virus, so this is a rapidly changing situation.
The CDC recommends use of the antiviral drug Tamiflu (oseltamivir) and Relenza (zanamivir) to treat infection with the H1N1 virus or to prevent infection if you are exposed to someone with the flu.
However, it is recommended that anyone with respiratory problems should avoid using Relenza.
Flu shots to be available in September and October
A vaccine (flu shot) to protect against the H1N1 virus is expected to be available by the second half of October. This vaccine will need to be given twice, with the second shot administered at least 21 days after the first.
In addition, a vaccine to protect against the usual seasonal flu (single injection) will be available in September. It is recommended that anyone with lung problems receive all three of these injections this fall.
